Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 2

Status

Completed 3Withdrawn 1

Sponsor Class

OTHER 7INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 2Sarcoma 1

Conditions

Neoplasms 3Back Pain 3Osteoporosis 2Multiple Myeloma 2Spinal Fractures 1Bone Neoplasms 1Bone Diseases, Metabolic 1

Interventions

pembrolizumab 1033Carboplatin 971Paclitaxel 942Gemcitabine 799Cisplatin 757Docetaxel 698Bevacizumab 637Nivolumab 520Pemetrexed 507Capecitabine 475Cyclophosphamide 473Fluorouracil 425Dexamethasone 410Rituximab 391Oxaliplatin 352Injections 347Trastuzumab 314atezolizumab 312Cetuximab 291Leucovorin 290Irinotecan 271130-nm albumin-bound paclitaxel 257Prednisone 251Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 219durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Kyphoplasty × Clear all
NCT00211237 2021-01-05

CAFE

Medtronic Spinal and Biologics

Phase NA Completed
134 enrolled 37 charts

Back Pain, Neoplasms, Spinal Fractures

NCT00211211 2017-12-08

FREE Study - Fracture Reduction Evaluation

Medtronic Spinal and Biologics

Phase 4 Completed
300 enrolled
Plasma cellSarcoma

Back Pain, Bone Diseases, Metabolic, Bone Neoplasms, Multiple Myeloma, Osteoporosis

NCT01871519 2017-03-29

EVOLVE

Medtronic Spinal and Biologics

Phase NA Completed
354 enrolled 28 charts

Neoplasms, Osteoporosis

NCT01410929 2017-01-20

MM

Merit Medical Systems, Inc.

Phase 4 Withdrawn
Plasma cell

Back Pain, Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡